September 2016

CRANBURY, N.J., Sept. 23, 2016 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced that a review of the neurobiology and treatment efficacy of bremelanotide for hypoactive sexual desire disorder (“HSDD”) was presented at the …

Palatin Technologies Presents Bremelanotide Neurobiology and Treatment Efficacy Review at World Meeting on Sexual Medicine Read More »

CRANBURY, N.J., Sept. 23, 2016 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced that as previously disclosed in its Annual Report on Form 10-K for the year ended June 30, 2016, which was …

Palatin Technologies Receives Audit Opinion with Going Concern Explanation Read More »

CRANBURY, N.J., Sept. 20, 2016 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced financial results for its fourth quarter and fiscal year ended June 30, 2016.  Significant Highlights Bremelanotide – Under development …

Palatin Technologies, Inc. Reports Fourth Quarter And Fiscal Year 2016 Results Read More »

CRANBURY, N.J., Sept. 14, 2016 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter, fiscal year end 2016 operating results on Tuesday, September 20, 2016  before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on September …

Palatin Technologies, Inc. to Report Fourth Quarter Fiscal Year End 2016 Results; Teleconference and Webcast to be held on September 20, 2016 Read More »